BRK-B vs PSEC
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
PSEC exhibits significant financial distress as evidenced by a weak Piotroski F-Score of 2/9 and a bearish technical trend. While the stock trades at a deep discount to book value (P/B 0.45), this is offset by an unsustainable dividend payout ratio of 211.76% and negative profit margins. The combination of negative ROE and a current ratio below 1.0 suggests liquidity risks and poor capital efficiency. Despite short-term price momentum, the long-term trajectory and fundamental health indicators point to a 'yield trap' scenario.
Compare Another Pair
Related Comparisons
BRK-B vs PSEC: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and Prospect Capital Corporation (PSEC) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.